Emma Moulton
Research Fellow at Nodes Advisors AG- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Nodes Advisors AG
-
Switzerland
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Research Fellow
-
Oct 2021 - Present
Zurich, Switzerland
-
-
-
Prellis Biologics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Antibody Project Manager
-
Nov 2020 - Jul 2021
San Francisco Bay Area Developing novel antibodies against infectious disease (including COVID-19) and cancer using 3d printed lymph node organoids.
-
-
Consultant
-
Jul 2020 - Nov 2020
San Francisco Bay Area
-
-
Associate Scientist
-
Apr 2020 - Jul 2020
San Francisco Bay Area Developing novel antibodies against COVID-19 using 3d-printed lymph node organoids.
-
-
-
UCSF Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Assistant Specialist
-
Mar 2018 - Jul 2020
San Francisco, California Designing a CAR-T cell that provides an element of clinical control over this highly promising, but sometimes toxic, therapy.
-
-
-
Prellis Biologics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Associate Scientist
-
Aug 2016 - Feb 2018
San Francisco Bay Area -1st employee -IP development, proof-of-concept work, and early business development for laser-based 3d bioprinting startup. -Generated novel antibodies against emerging infectious diseases and other targets using 3d-printed lymph node organoids.
-
-
Education
-
University of California, Los Angeles
MD-PhD Candidate, Immunology